# Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia

> **NCT00020670** · EARLY_PHASE1 · TERMINATED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 9 (actual)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** CD 40

## Key facts

- **NCT ID:** NCT00020670
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-02-20
- **Primary completion:** 2003-04-01
- **Final completion:** 2003-07-01
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2017-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00020670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00020670, "Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00020670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*